The News Review:

- Awards celebrating women and biotech brilliance
- ‘Top 5′ Priorities from Cancer Centers Guide ncore Evolution
- The Standard – Hong Kong’s First FREE English Newspaper
- Astronaut Biography: Dafydd ‘Dave’ R. Williams
- Research Demonstrates Effectiveness f Poly-MVAF For Cancer Patients
- Risky gay sex ‘behind HIV epidemic’

Awards celebrating women and biotech brilliance
eurekalert.org – Jul 20, 2007
QCTN is based in Queensland Australia and was established in 2005 by the Queensland Government as part ofits Smart State Initiative. It is an incorporated association of Queensland based life sciences researchorganisations and related entities. QCTN itself does not conduct any form of clinical research; rather QCTN is an’umbrella organisation’. As a visible point of contact for domestic and international organisations seeking to undertake preclinical andclinical research in Australia QCTN helps identify and connect organisations (sponsors) with appropriateresearch institutions hospitals CRs and other life sciences service providers. QCTN now has more than 55entities as members. ###For further information on QCTN please visit their website.

‘Top 5′ Priorities from Cancer Centers Guide ncore Evolution
prweb.com – Jul 20, 2007
By addressing this Unity in Diversity ncore has become the most comprehensive clinical research and biorepository management system that is available in the marketplace today. As great as this might sound institutions still have individual priorities which may or may not coincide with the collective priorities. To address this aspect of Diversity in Unity earlier this year each of the 20 ncore centers was requested to present up to five enhancement suggestions known as their "Top 5. " Each of these requests were elaborated evaluated and prioritized in collaboration with the respective cancer centers. "For us the notion of Unity in Diversity has always meant that in addition to tracking regulations and the collective needs of all centers we must also ensure that ncore addresses workflow-related nuances and other critical needs that may be unique to a specific institution" says Srini Kalluri president and CE of PercipEnz Technologies makers of ncore.

The Standard – Hong Kong’s First FREE English Newspaper
The Standard – Jul 20, 2007
Cooper said while cocktails of powerful anti- retroviral drugs had been used to help contain the virus and prolong life for more than a decade the new drugs were more potent than their predecessors and had fewer side effects. Cooper the director of Australia’s National Center for HIV Epidemiology and Clinical Research said integrase inhibitors and other promising research avenues such as gene therapy meant eradicating HIV was a realistic possibility. “The integrase inhibitors are particularly potent drugs and I think you will start to see that eradication will return to the agenda with these new agents and new ways of using them” Cooper said. “Eradication was talked about when anti- retroviral therapies became available in the mid- 1990s but went off the agenda because of the toxicity of the drugs – people thought it was going to take 50 years. “Now with some of the newer drugs and newer strategies it’s back on the agenda again. Cooper said up to 30 drugs were now available to HIV patients in the developed world meaning they live longer but present a challenge to the health systems that treat them because they are more prone to conditions such as heart disease and cancer.

Astronaut Biography: Dafydd ‘Dave’ R. Williams
Space.com – Jul 20, 2007
EXPERIENCE: Dave Williams pursued postgraduate studiesin advanced invertebrate physiology at the Friday HarbourLaboratories at the University of Washington Seattle but his interestsshifted to vertebrate neurophysiology when for his master’s thesis he becameinvolved in basic science research on how adrenal steroid hormones modify theregulation of sleep-wake cycles. While working in the NeurophysiologicalLaboratories at the Allan Memorial Institute for Psychiatry Williams assistedin clinical studies of slow wave potentials within the central nervous system. Hisclinical research in emergency medicine has included studies evaluating theinitial training and skill retention of cardiopulmonary resuscitation (CPR)skills patient survival from out-of-hospital cardiac arrest the earlyidentification of trauma patients at high risk and the efficacy of tetanusimmunization in the elderly. In 1988Williams became an emergency physician with the Department of EmergencyServices at Sunnybrook Health Science Centre while also lecturing with the Departmentof Surgery at the University of Toronto. He served as a member of the AirAmbulance Utilization Committee with the Ministry of Health in ntario both asan academic emergency physician and later as a representative of communityemergency physicians. In addition he has trained basic ambulance attendantsparamedics nurses residents and practicing physicians in cardiac and traumaresuscitation with both the Canadian Heart and Stroke Foundation and theAmerican College of Surgeons. From 1989to 1990 Williams served as an emergency physician with the Emergency Associatesof Kitchener Waterloo and as the medical director of the WestmountUrgent Care Clinic.

Research Demonstrates Effectiveness f Poly-MVAF For Cancer Patients
emaxhealth.com – Jul 20, 2007
Unlike conventional chemotherapy Poly-MVA can be continued indefinitely. The best results appear to be achieved when it is taken for periods of time of 3 months or greater. "A patented supplement with over 12 years of testing and clinical research and over 40 years of laboratory research Poly-MVA is a nutritional supplement that is uniquely formulated combination of minerals vitamins and amino acids designed to support cellular energy production promote overall health and protection and boost immune system function — particularly in compromised body states. Poly-MVA is prepared using a unique method that combines the ingredients and produces a compound that is not only safe and effective (unlike most chemotherapeutic compounds which break down accumulate in tissue and eventually become toxic) but also supports and protects healthy cells as well. Most chemotherapeutic agents have significant side effects and negative long- term health implications. Poly-MVA is distributed worldwide by AMARC Enterprises a San Diego-based nutraceutical company.

Risky gay sex ‘behind HIV epidemic’
Sydney Morning Herald – Jul 20, 2007
The major survey of HIV rates found that 12313 Australians wereinfected with the lifetime disease in the 13 years between 1993 and2006. The number of new infections dropped 30 per cent in the 1990sand then climbed back to the same high between 2000 and 2006. Professor John Kaldor deputy director at the National Centre inHIV Epidemiology and Clinical Research said the rise was duemainly to risky sexual behaviour among gay men. Virus exposure through male-to-male sex accounted for 70 percent of all cases followed by heterosexual contact at 18 percent. In more than half of heterosexually-acquired cases the personwas born in or had a partner from a country with a high prevalenceof HIV. Exposure to HIV from injecting drug use was relatively rareProf Kaldor said. The study also found that in NSW – historically the state withthe highest HIV rate – numbers have remained stable for the pastfive years.